Cathy Sila, MD
- Director, Stroke Center, Neurological Institute, University Hospitals
- Chair, Department of Neurology, Neurological Institute, University Hospitals
- Chair, Department of Neurology, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
- Gilbert W Humphrey Endowed Chair in Neurology, University Hospitals
- Inaugural Distinguished Senior Attending Physician, University Hospitals
- Specialty: Neurology-Vascular Neurology, Neurology
-
Location:UH Cleveland Minoff Health Center
3909 Orange Pl
Beachwood, OH 44122
- Call: 216-285-5115
Biography: Cathy Sila, MD
Expertise
Certifications & Memberships
- Vascular Neurology - American Board of Psychiatry and Neurology
- Neurology - American Board of Psychiatry and Neurology
Education
Fellowship | Cerebrovascular
Cerebrovascular - Cleveland Clinic (1985 - 1986)
Residency | Neurology
Neurology - Mayo Clinic College Of Medicine And Science (1983 - 1985)
Residency | Neurology
Neurology - Cleveland Clinic (1982 - 1983)
Internship | Internal Medicine
Internal Medicine - Cleveland Clinic (1981 - 1982)
Medical Education
Case Western Reserve University School Of Medicine (1981)
Undergraduate
Miami University (1977)
About
Cathy Sila MD, FAAN, FAHA, is the Chair of the Department of Neurology at University Hospitals. She holds the Gilbert W. Humphrey Endowed Chair in Neurology and was the first Distinguished Senior Attending Physician in Neurology at University Hospitals. A Professor of Neurology at Case Western Reserve University School of Medicine, Dr. Sila is an internationally recognized vascular neurologist. She previously served as the vice chair in the Department of Neurology for Clinical Activities & Quality and serves as chair of the University Hospitals System Stroke Program, which is recognized as a system integration model for health care delivery.
Dr. Sila is a recognized expert in preventing and treating stroke, neurologic complications of heart disease, and defining outcomes for clinical trials. As the first woman to chair neurology at UH, her priorities include ensuring access to innovative, high-value care integrated throughout the health system, supporting the provider-patient relationship and experience, training the next generation through the many fellowships and one of the largest neurology residency programs in the country, and promoting research that improves the quality of life for patients with neurologic diseases.
Dr. Sila received undergraduate degrees in Chemistry and Zoology and graduated from Case Western Reserve University School of Medicine. She completed her Neurology residency at the Mayo Clinic, followed by Fellowship training in Cerebrovascular Research at the Cleveland Clinic. She has extensive clinical research and research administration and core lab experience for more than 100 clinical trials, data element developer for the FDA and NINDS, and expert panel advisor for emerging technologies and therapeutics.
Dr. Sila has received numerous honors, was elected to AHA/ASA and AAN executive committees, and was appointed to national directorship and institutional leadership boards. She was an inaugural UH Distinguished Senior Attending Physician and has received awards from the American Heart Association National Stroke Council, YWCA Women of Professional Excellence and Crain's Cleveland Business Healthcare Hero. She is consistently named among America's Top Doctors by Castle-Connelly and is one of their Exceptional Women in Medicine.
Research & Publications
Research Interests
Clinical Trials Design, Administration, & Clinical Events Adjudication | Cerebrovascular Complications of Cardiovascular Tests & Procedures | Stroke Systems of Care
Featured Videos
Watch to find out more about this University Hospitals provider.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Cathy Sila disclosed the following Outside Relationships with Industry:
- - Hoffman LaRoche - Consulting
- - Monteris Medical, Inc. - Ownership